title: [Pharmacological treatment of chronic heart failure in patients with renal failure].
authors.affiliation: I Katedra i Klinika Kardiologii AM w Warszawie, ul. Banacha 1a, 02-097 Warsaw, Poland.
authors.forename: Sławomir
authors.initials: S
authors.lastname: Stawicki
authors.forename: Małgorzata H
authors.initials: MH
authors.lastname: Starczewska
authors.forename: Marek
authors.initials: M
authors.lastname: Roik
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Opolski
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000318:Adrenergic beta-Agonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002301:Cardiac Glycosides; D002317:Cardiovascular Agents; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists